Protalix Biotherapeutics Inc (PLX)
EBITDA Growth
149.10%
TTM · Period ending:
PLX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported149.10%period ending
Latest reported149.10%period ending
PLX TTM EBITDA YoY % (-654.55% → 149.10%)
Year-over-year change
High-resolution chart · PNG
PLX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 50.7872% | |
| 54.1374% | |
| 41.5691% | |
| 82.4592% | |
| 26.5279% | |
| 1.8051% | |
| 29.0213% | |
| -326.5966% | |
| -41.6572% | |
| 2.4177% | |
| -46.0317% | |
| -60% | |
| -654.5455% |